The microfluidics industry is boosted by the COVID-19 outbreak

“Wherever we look, in most applications, we’re in a period where volumes are ramping up rapidly” asserts Sébastien Clerc, Technology & Market Analyst in Microfluidics, Sensing & Actuating at Yole Développement (Yole). “This is a sign of the technology and the business models maturing. The main hurdles are behind us. The sale of consumables is still the main model in microfluidics, however companies are finding more convenient solutions for their customers”.

For example, different companies are developing consumables for a common instrument so that customers only have to purchase a single instrument to run many types of test. Reagent rental options also diversify and take various forms, always to facilitate adoption. Indeed, successful commercialization of microfluidic products and devices is improving, but still not easy.

Besides point-of-care testing, the market is driven by tools for pharmaceutical and life science research. These include DNA sequencing, other genomics and proteomics tools, and much more. Veterinary testing is also enjoying very nice dynamics, with several significant new entrants. Moreover, new applications include liquid lenses, which enable miniaturized and enhanced optical actuation. These are now reaching commercialization and show tremendous potential for industrial and consumer applications. It confirms once again that microfluidic technologies are not limited to life sciences and healthcare.

In this context, Yole releases a new dedicated report, Status of the Microfluidics Industry 2020. Yole’s analysts explain COVID-19’s impact on the microfluidics industry and detail their vision of this industry’s evolution. Including for the first time market shares of integrators on eight segments of the microfluidics market, along with market shares of microfluidic fabs, this report presents readers a comprehensive understanding of the competitive environment within this industry. This study also points out market segmentation, data and forecasts, market and technology trends. In addition, the report offers an analysis of recent industry moves, including fundraising and M&A. This year, it also provides an understanding of the opportunities in terms of glass and silicon wafers in the microfluidics field.

What is the status of the microfluidics industry? What is the impact on the COVID-19 in short and long terms? Who are the key players? Who will be the main winners and why? Yole’s analysts shed light on the overall microfluidics ecosystem.

For Sébastien Clerc in the Status of the Microfluidics Industry 2020 report: “Following the advent of COVID-19 in early 2020, our society has encountered an unprecedented health and economic situation. Many countries around the world have had either partial or complete lockdowns for different durations. It’s been more than six months and the situation is far from returning to normal, although life continues.”Full article


Related presentations

Liked this post?

Share it on your social networks